Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
Michihiro Iwaki(Yokohama City University), Masato Yoneda(Yokohama City University Hospital)
Cited by 3
Related Papers
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
|JAMA|2024|200
Association of single-nucleotide polymorphisms in MTMR9 gene with obesity
|Human Molecular Genetics|2007|53
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
|Journal of Hepatology|2025|35